<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d220">
    <sentence id="DDI-DrugBank.d220.s0" text="Drug-drug interactions with Mefloquine have not been explored in detail.">
        <entity id="DDI-DrugBank.d220.s0.e0" charOffset="28-37"
            type="drug" text="Mefloquine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d220.s1" text="There is one report of cardiopulmonary arrest, with full recovery, in a patient who was taking a beta blocker (propranolol).">
        <entity id="DDI-DrugBank.d220.s1.e0" charOffset="97-108"
            type="group" text="beta blocker"/>
        <entity id="DDI-DrugBank.d220.s1.e1" charOffset="111-121"
            type="drug" text="propranolol"/>
    </sentence>
    <sentence id="DDI-DrugBank.d220.s2" text="The effects of Mefloquineuine on the compromised cardiovascular system have not been evaluated."/>
    <sentence id="DDI-DrugBank.d220.s3" text="The benefits of Mefloquine therapy should be weighed against the possibility of adverse effects in patients with cardiac disease.">
        <entity id="DDI-DrugBank.d220.s3.e0" charOffset="16-25"
            type="drug" text="Mefloquine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d220.s4" text="Because of the danger of a potentially fatal prolongation of the QTc interval, halofantrine must not be given simultaneously with or subsequent to Mefloquine.">
        <entity id="DDI-DrugBank.d220.s4.e0" charOffset="79-90"
            type="drug" text="halofantrine"/>
        <entity id="DDI-DrugBank.d220.s4.e1" charOffset="147-156"
            type="drug" text="Mefloquine"/>
        <ddi id="DDI-DrugBank.d220.s4.d0" e1="DDI-DrugBank.d220.s4.e0"
            e2="DDI-DrugBank.d220.s4.e1" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d220.s5" text="Concomitant administration of Mefloquine and other related compounds (eg, quinine, quinidine and chloroquine) may produce electrocardiographic abnormalities and increase the risk of convulsions.">
        <entity id="DDI-DrugBank.d220.s5.e0" charOffset="30-39"
            type="drug" text="Mefloquine"/>
        <entity id="DDI-DrugBank.d220.s5.e1" charOffset="74-80"
            type="drug" text="quinine"/>
        <entity id="DDI-DrugBank.d220.s5.e2" charOffset="83-91"
            type="drug" text="quinidine"/>
        <entity id="DDI-DrugBank.d220.s5.e3" charOffset="97-107"
            type="drug" text="chloroquine"/>
        <ddi id="DDI-DrugBank.d220.s5.d0" e1="DDI-DrugBank.d220.s5.e0"
            e2="DDI-DrugBank.d220.s5.e1" type="effect"/>
        <ddi id="DDI-DrugBank.d220.s5.d1" e1="DDI-DrugBank.d220.s5.e0"
            e2="DDI-DrugBank.d220.s5.e2" type="effect"/>
        <ddi id="DDI-DrugBank.d220.s5.d2" e1="DDI-DrugBank.d220.s5.e0"
            e2="DDI-DrugBank.d220.s5.e3" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d220.s6" text="If these drugs are to be used in the initial treatment of severe malaria, Mefloquine administration should be delayed at least 12 hours after the last dose.">
        <entity id="DDI-DrugBank.d220.s6.e0" charOffset="74-83"
            type="drug" text="Mefloquine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d220.s7" text="There is evidence that the use of halofantrine after Mefloquineuine causes a significant lengthening of the QTc interval.">
        <entity id="DDI-DrugBank.d220.s7.e0" charOffset="34-45"
            type="drug" text="halofantrine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d220.s8" text="Clinically significant QTc prolongation has not been found with Mefloquineuine alone."/>
    <sentence id="DDI-DrugBank.d220.s9" text="This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.">
        <entity id="DDI-DrugBank.d220.s9.e0" charOffset="78-87"
            type="drug" text="Mefloquine"/>
        <entity id="DDI-DrugBank.d220.s9.e1" charOffset="185-199"
            type="drug" text="anti-arrhythmic"/>
        <entity id="DDI-DrugBank.d220.s9.e2" charOffset="204-234"
            type="group" text="beta-adrenergic blocking agents"/>
        <entity id="DDI-DrugBank.d220.s9.e3" charOffset="237-260"
            type="group" text="calcium channel blockers"/>
        <entity id="DDI-DrugBank.d220.s9.e4" charOffset="263-276"
            type="group" text="antihistamines"/>
        <entity id="DDI-DrugBank.d220.s9.e5" charOffset="281-298"
            type="group" text="H1-blocking agents"/>
        <entity id="DDI-DrugBank.d220.s9.e6" charOffset="301-325"
            type="group" text="tricyclic antidepressants"/>
        <entity id="DDI-DrugBank.d220.s9.e7" charOffset="331-344"
            type="group" text="phenothiazines"/>
        <ddi id="DDI-DrugBank.d220.s9.d0" e1="DDI-DrugBank.d220.s9.e0"
            e2="DDI-DrugBank.d220.s9.e1" type="effect"/>
        <ddi id="DDI-DrugBank.d220.s9.d1" e1="DDI-DrugBank.d220.s9.e0"
            e2="DDI-DrugBank.d220.s9.e2" type="effect"/>
        <ddi id="DDI-DrugBank.d220.s9.d2" e1="DDI-DrugBank.d220.s9.e0"
            e2="DDI-DrugBank.d220.s9.e3" type="effect"/>
        <ddi id="DDI-DrugBank.d220.s9.d3" e1="DDI-DrugBank.d220.s9.e0"
            e2="DDI-DrugBank.d220.s9.e4" type="effect"/>
        <ddi id="DDI-DrugBank.d220.s9.d4" e1="DDI-DrugBank.d220.s9.e0"
            e2="DDI-DrugBank.d220.s9.e5" type="effect"/>
        <ddi id="DDI-DrugBank.d220.s9.d5" e1="DDI-DrugBank.d220.s9.e0"
            e2="DDI-DrugBank.d220.s9.e6" type="effect"/>
        <ddi id="DDI-DrugBank.d220.s9.d6" e1="DDI-DrugBank.d220.s9.e0"
            e2="DDI-DrugBank.d220.s9.e7" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d220.s10" text="There are no data that conclusively establish whether the concomitant administration of Mefloquineuine and the above listed agents has an effect on cardiac function."/>
    <sentence id="DDI-DrugBank.d220.s11" text="In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.">
        <entity id="DDI-DrugBank.d220.s11.e0" charOffset="22-35"
            type="group" text="anticonvulsant"/>
        <entity id="DDI-DrugBank.d220.s11.e1" charOffset="42-54"
            type="drug" text="valproic acid"/>
        <entity id="DDI-DrugBank.d220.s11.e2" charOffset="57-69"
            type="drug" text="carbamazepine"/>
        <entity id="DDI-DrugBank.d220.s11.e3" charOffset="72-84"
            type="drug" text="phenobarbital"/>
        <entity id="DDI-DrugBank.d220.s11.e4" charOffset="89-97"
            type="drug" text="phenytoin"/>
        <entity id="DDI-DrugBank.d220.s11.e5" charOffset="124-133"
            type="drug" text="Mefloquine"/>
        <entity id="DDI-DrugBank.d220.s11.e6" charOffset="199-212"
            type="group" text="anticonvulsant"/>
        <ddi id="DDI-DrugBank.d220.s11.d0" e1="DDI-DrugBank.d220.s11.e0"
            e2="DDI-DrugBank.d220.s11.e5" type="effect"/>
        <ddi id="DDI-DrugBank.d220.s11.d1" e1="DDI-DrugBank.d220.s11.e1"
            e2="DDI-DrugBank.d220.s11.e5" type="effect"/>
        <ddi id="DDI-DrugBank.d220.s11.d2" e1="DDI-DrugBank.d220.s11.e2"
            e2="DDI-DrugBank.d220.s11.e5" type="effect"/>
        <ddi id="DDI-DrugBank.d220.s11.d3" e1="DDI-DrugBank.d220.s11.e3"
            e2="DDI-DrugBank.d220.s11.e5" type="effect"/>
        <ddi id="DDI-DrugBank.d220.s11.d4" e1="DDI-DrugBank.d220.s11.e4"
            e2="DDI-DrugBank.d220.s11.e5" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d220.s12" text="Therefore, patients concurrently taking antiseizure medication and Mefloquine should have the blood level of their antiseizure medication monitored and the dosage adjusted appropriately.">
        <entity id="DDI-DrugBank.d220.s12.e0" charOffset="67-76"
            type="drug" text="Mefloquine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d220.s13" text="When Mefloquine is taken concurrently with oral live typhoid vaccines, attenuation of immunization cannot be excluded.">
        <entity id="DDI-DrugBank.d220.s13.e0" charOffset="5-14"
            type="drug" text="Mefloquine"/>
        <entity id="DDI-DrugBank.d220.s13.e1" charOffset="48-68"
            type="group" text="live typhoid vaccines"/>
        <ddi id="DDI-DrugBank.d220.s13.d0" e1="DDI-DrugBank.d220.s13.e0"
            e2="DDI-DrugBank.d220.s13.e1" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d220.s14" text="Vaccinations with attenuated live bacteria should therefore be completed at least 3 days before the first dose of Mefloquine.">
        <entity id="DDI-DrugBank.d220.s14.e0" charOffset="114-123"
            type="drug" text="Mefloquine"/>
    </sentence>
    <sentence id="DDI-DrugBank.d220.s15" text="No other drug interactions are known."/>
    <sentence id="DDI-DrugBank.d220.s16" text="Nevertheless, the effects of Mefloquine on travelers receiving comedication, particularly diabetics or patients using anticoagulants, should be checked before departure.">
        <entity id="DDI-DrugBank.d220.s16.e0" charOffset="29-38"
            type="drug" text="Mefloquine"/>
        <entity id="DDI-DrugBank.d220.s16.e1" charOffset="118-131"
            type="group" text="anticoagulants"/>
        <ddi id="DDI-DrugBank.d220.s16.d0" e1="DDI-DrugBank.d220.s16.e0"
            e2="DDI-DrugBank.d220.s16.e1" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d220.s17" text="In clinical trials, the concomitant administration of sulfadoxine and pyrimethamine did not alter the adverse reaction profile.">
        <entity id="DDI-DrugBank.d220.s17.e0" charOffset="54-64"
            type="drug" text="sulfadoxine"/>
        <entity id="DDI-DrugBank.d220.s17.e1" charOffset="70-82"
            type="drug" text="pyrimethamine"/>
    </sentence>
</document>
